Kazazian Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-14,308	Closed	-$568K	–	101
2015 Q1	$568K	Sell	14,308 -14,030	-50%	-$557K	0.75%	26
2014 Q4	$633K	Buy	+28,338	New	+$633K	0.55%	35